# ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

> **NCT03462498** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Kyoto University, Graduate School of Medicine** · enrollment: 3008 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Acute Myocardial Infarction
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors

## Interventions

- **DRUG:** 1-months DAPT
- **DRUG:** 12-month DAPT

## Key facts

- **NCT ID:** NCT03462498
- **Lead sponsor:** Kyoto University, Graduate School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-02
- **Primary completion:** 2021-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 3008 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462498, "ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03462498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*